News Home

Is Mersana Therapeutics Inc (MRSN) A Winner in the Healthcare Sector?

Wednesday, September 09, 2020 12:26 PM | InvestorsObserver Analysts
Is Mersana Therapeutics Inc (MRSN) A Winner in the Healthcare Sector?

Mersana Therapeutics Inc (MRSN) is near the top in its sector according to InvestorsObserver.

MRSN gets an overall rating of 77. That means it scores higher than 77% of stocks.

Mersana Therapeutics Inc gets a 79 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 77
MRSN has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on MRSN!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 77 means the stock is more attractive than 77 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.

The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Mersana Therapeutics Inc Stock Today?

Mersana Therapeutics Inc (MRSN) stock is trading at $18.32 as of 12:11 PM on Wednesday, Sep 9, a gain of $0.96, or 5.53% from the previous closing price of $17.36. The stock has traded between $17.18 and $18.38 so far today. Volume today is less active than usual. So far 272,375 shares have traded compared to average volume of 550,727 shares.

Click Here to get the full Stock Score Report on Mersana Therapeutics Inc (MRSN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App